Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

(2011) A Serpa Neto et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer

(2010) Vahakn B. Shahinian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values

(2009) Vivek K. Wadhwa et al.   BJU INTERNATIONAL

Assessment of fracture risk

(2009) John A. Kanis et al.   EUROPEAN JOURNAL OF RADIOLOGY

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

(2009) Dana Bliuc   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer

(2008) Grace L. Lu-Yao   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Analysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables

(2008) James R. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY